# HCA — AI stock forecast & analysis

> AI-generated analysis by K3vl4r — 2026-07-31. Informational only, not financial advice.

**Recommendation:** ACCUMULATE

**Scores (0–100):** Overall 7 · Fundamentals 7.3 · Technicals 6.7 · Growth 7.4 · Risk 6.3

## Summary

HCA Healthcare faces near-term headwinds from policy-driven revenue pressure but demonstrates resilient fundamentals with strong operating margins and cash flow. The recent $400M pre-tax hit to earnings is offset by robust operational performance and institutional ownership, though valuation remains pressured by negative equity and high debt. Technicals show a mean-reversion bias toward the $400 support level with Kronos AI forecasts suggesting upside potential.

## Price targets (12-month horizon)

- Bear: $377.50
- Base: $435.00
- Bull: $502.50

## News context

The most critical news is HCA's $400M pre-tax hit from policy changes affecting insurance coverage, which explains the recent stock decline despite strong Q2 results. Analysts have lowered price targets (Goldman Sachs to $485, Mizuho to $475), but institutional ownership remains high at 63.3%. The Kronos AI forecast suggests a mean-reversion bias toward $400 support with upside potential.

## About
- Methodology: https://app.k3vl4r.com/methodology
- Full report: https://app.k3vl4r.com/r/hca-ai-stock-forecast-0c2d198a30543e222897cf9b48783d23
- AI-generated; model outputs can be wrong. Not financial advice.